Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics.
Oerlemans R, Ruiz-Moreno AJ, Cong Y, Dinesh Kumar N, Velasco-Velazquez MA, Neochoritis CG, Smith J, Reggiori F, Groves MR, Dömling A.
Oerlemans R, et al. Among authors: cong y.
RSC Med Chem. 2020 Dec 21;12(3):370-379. doi: 10.1039/d0md00367k.
RSC Med Chem. 2020.
PMID: 34041486
Free PMC article.